DE68919475D1 - Bivalente liganden, wirksam für die blockierung des enzyms acat. - Google Patents

Bivalente liganden, wirksam für die blockierung des enzyms acat.

Info

Publication number
DE68919475D1
DE68919475D1 DE68919475T DE68919475T DE68919475D1 DE 68919475 D1 DE68919475 D1 DE 68919475D1 DE 68919475 T DE68919475 T DE 68919475T DE 68919475 T DE68919475 T DE 68919475T DE 68919475 D1 DE68919475 D1 DE 68919475D1
Authority
DE
Germany
Prior art keywords
effective
block
acat enzyme
bivalent ligands
acat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919475T
Other languages
English (en)
Other versions
DE68919475T2 (de
Inventor
Ronald Gammill
Frank Bell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DE68919475D1 publication Critical patent/DE68919475D1/de
Publication of DE68919475T2 publication Critical patent/DE68919475T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE68919475T 1988-08-16 1989-06-16 Bivalente liganden, wirksam für die blockierung des enzyms acat. Expired - Fee Related DE68919475T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23293188A 1988-08-16 1988-08-16
PCT/US1989/002572 WO1990002129A1 (en) 1988-08-16 1989-06-16 Bivalent ligands effective for blocking acat enzyme

Publications (2)

Publication Number Publication Date
DE68919475D1 true DE68919475D1 (de) 1995-01-05
DE68919475T2 DE68919475T2 (de) 1995-05-11

Family

ID=22875168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919475T Expired - Fee Related DE68919475T2 (de) 1988-08-16 1989-06-16 Bivalente liganden, wirksam für die blockierung des enzyms acat.

Country Status (7)

Country Link
EP (1) EP0429464B1 (de)
JP (1) JPH04500506A (de)
KR (1) KR900701792A (de)
AT (1) ATE114311T1 (de)
DE (1) DE68919475T2 (de)
DK (1) DK25691D0 (de)
WO (1) WO1990002129A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304548A (en) * 1988-08-16 1994-04-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5180717A (en) * 1988-08-16 1993-01-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
AU2291195A (en) * 1994-04-12 1995-10-30 Qualcomm Incorporated Method and apparatus for freight transportation using a satellite navigation system
EP2208728A4 (de) * 2007-09-19 2011-12-21 Inst Med Molecular Design Inc Heterocyclisches derivat mit hemmender wirkung auf 11-?-hydroxysteroiddehydrogenase vom typ i
JP5291126B2 (ja) * 2008-03-05 2013-09-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 三環式ピリジン誘導体、そのような化合物を含有する医薬、それらの使用及びそれらの調製方法
BR112012020591A2 (pt) 2010-02-19 2017-10-10 Boehringer Ingelheim Int derivados de piridina tricíclica, medicamentos contendo tais compostos, seu uso e processo para sua preparação.
AR087577A1 (es) 2011-08-17 2014-04-03 Boehringer Ingelheim Int Derivados de furo[3,4-c]quinolina, medicamentos que contienen dichos compuestos, su uso y proceso para su preparacion
CN107021940A (zh) * 2017-05-03 2017-08-08 天津国际生物医药联合研究院 一种双哌嗪类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529561B2 (en) * 1979-02-13 1983-06-09 Upjohn Company, The Antiatherogenic 6-halofurochromones
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions

Also Published As

Publication number Publication date
WO1990002129A1 (en) 1990-03-08
DE68919475T2 (de) 1995-05-11
DK25691A (da) 1991-02-14
KR900701792A (ko) 1990-12-04
EP0429464A1 (de) 1991-06-05
DK25691D0 (da) 1991-02-14
ATE114311T1 (de) 1994-12-15
AU3835889A (en) 1990-03-23
AU631801B2 (en) 1992-12-10
JPH04500506A (ja) 1992-01-30
EP0429464B1 (de) 1994-11-23

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
DE69008010D1 (de) Sauerstoffdelignifizierung und enzymatische Behandlung.
WO2001049830A3 (en) Improved lysosomal enzymes and lysosomal enzyme activators
TR199501643A2 (tr) Yünün enzimlerle tedavisi icin yöntem.
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
WO1996021730A3 (en) Ribozymes with rna protein binding site
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
NO891940L (no) Fremgangsmaate for selektivt aa redusere permeabiliteten avoljefrie soner i underjordiske formasjoner.
DE68919475D1 (de) Bivalente liganden, wirksam für die blockierung des enzyms acat.
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
ES8605476A1 (es) Un procedimiento para preparar un derivado de acido benzoico.
DE3770184D1 (de) Behandlung von gasstroemen.
DE69613329D1 (de) Enzym enthaltendes Granulat, Herstellungsmethode und das Granulat enthaltende Zusammensetzungen
GB1533205A (en) Plasmin fractions and complexes thereof
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
NO904057L (no) Alkalisk pullulanase y med alfa-amylaseaktivitet, mikroorgansime somproduserer denne og fremgangsmaate ved fremstilling derav.
LV12149A (lv) 5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
NO871477L (no) Fremgangsmaate for fremstilling av human plasminogenaktivator.
IE811449L (en) Pyrrolidine derivatives.
FR2587085B1 (fr) Profiles et leurs pieces d'assemblage pour la confection, avec des panneaux, de cloisons et de mobiliers demontables et recuperables
IT8921592A0 (it) Stabilizzazione in forma liquida dell'enzima glucosio ossidasi.
NO903056L (no) Fremgangsmaate ved glukoseoksydasebehandling av matvarer.
EP0298088A4 (de) Herstellung und verwendung von antikörpern zur diagnose von pankreatischer alpha-amylase.
NO872476D0 (no) Cephalosporinforbindelser og fremgangsmaate for fremstilling av disse.
Park Inhibition of Korean radish peroxidase by sodium azide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee